Oxa-steroids derivatives as selective progesterone receptor modulators

Details for Australian Patent Application No. 2007217101 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Kang, Fu-an; Sui, Zhihua; Jain, Nareshkumar F.

Agent Shelston IP

Pub. Number AU-A-2007217101

PCT Pub. Number WO2007/098388

Priority 60/775,042 17.02.06 US

Filing date 16 February 2007

Wipo publication date 30 August 2007

International Classifications

C07J 73/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 5/36 (2006.01) Drugs for disorders of the endocrine system

A61P 5/46 (2006.01) Drugs for disorders of the endocrine system

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/098388 Priority application(s): WO2007/098388

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007217109-Method of freeing the bound oil present in whole stillage and thin stillage

2007217100-Antihypertensive therapy